NCT03313362

Brief Summary

This is a prospective, comparative, multicenter study of subjects being admitted for standard of care therapy in Epilepsy Monitoring Units in the Veteran's Affair (VA) Medical Centers.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
71

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 18, 2017

Completed
16 days until next milestone

Study Start

First participant enrolled

November 3, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2019

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

December 20, 2019

Status Verified

December 1, 2019

Enrollment Period

1.6 years

First QC Date

October 10, 2017

Last Update Submit

December 18, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Test an independent group of epileptologist's ability to classify motor events between epileptic or non-epileptic using sEMG and audio.

    To test the null hypothesis that three independent epileptologists categorize, by majority vote, epileptic seizures and psychogenic non-epileptic seizures (identified utilizing vEEG review) correctly in no more than 70% of cases using sEMG and audio. We aim to test the null hypothesis that the epileptologists categorize epileptic seizures and psychogenic non-epileptic seizures correctly in no more than 70% of cases. The observed rate of correct classification will be compared to the rate of 70% under the null hypothesis using a two-sided binomial exact test.

    1 year

Secondary Outcomes (1)

  • To test the Brain Sentinel® Seizure Monitoring and Alerting System's ability to classify motor events as epileptic or non-epileptic.

    1 Year

Study Arms (1)

Subjects admitted to Epilepsy Monitoring Units in the VAMC

EXPERIMENTAL

Subjects being monitored by standard of care, video EEG, in the Epilepsy Monitoring Units in the VAMC will all be placed on a Seizure Monitoring and Alerting System (SPEAC System).

Device: SPEAC SystemDevice: video EEG

Interventions

Seizure Monitoring and Alerting System

Also known as: Brain Sentinel Seizure Monitoring and Alerting System
Subjects admitted to Epilepsy Monitoring Units in the VAMC
video EEGDEVICE

The Video EEG Monitoring Test (VEEG) is a high specialized form of an EEG test in where the patient is continuosly monitored by using a video recorder. This allows doctors to observe brainwaves activity during the time a seizure or spell is occurring.

Subjects admitted to Epilepsy Monitoring Units in the VAMC

Eligibility Criteria

Age22 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject has a history of suspected epileptic seizures with upper extremity motor involvement, or PNES with upper extremity motor involvement.
  • Is being admitted to a hospital for routine vEEG monitoring related to seizures.
  • Male or Female between the ages 22 to 99.
  • If female and of childbearing potential, has a negative pregnancy test and must not be nursing.
  • Can understand and sign written informed consent, or will have a parent or a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments.
  • Subject and/or Primary Caregiver must be competent to follow all study procedures.
  • Subject/LAR consents to the use of vEEG files, including video/audio recordings, for purposes of this research study.

You may not qualify if:

  • Intracranial EEG electrodes are being used.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Durham VAMC

Durham, North Carolina, 27705, United States

Location

Michael E DeBakey VA Medical Center

Houston, Texas, 77030, United States

Location

Hunter Holmes McGuire VA Medical Center

Richmond, Virginia, 23249, United States

Location

MeSH Terms

Conditions

Epilepsy, Partial, MotorPsychogenic Nonepileptic Seizures

Condition Hierarchy (Ancestors)

Epilepsies, PartialEpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesSeizuresNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Aatif Husain, MD

    Epilepsy Center of Excellence (ECoE) at the Durham VA Medical Center in Durham, North Carolina

    PRINCIPAL INVESTIGATOR
  • Alan Towne, MD

    Epilepsy Center of Excellence (ECoE) at Hunter Holmes McGuire VA Medical Center in Richmond, Virginia

    PRINCIPAL INVESTIGATOR
  • David Chen, MD

    Epilepsy Center of Excellence (ECoE) at the Michael E. DeBakey VA Medical Center in Houston, Texas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2017

First Posted

October 18, 2017

Study Start

November 3, 2017

Primary Completion

June 21, 2019

Study Completion

February 1, 2020

Last Updated

December 20, 2019

Record last verified: 2019-12

Locations